跳至主要内容
临床试验/NCT02029846
NCT02029846终止4 期

Glycemia in Diabetic Elders Trial

Johns Hopkins University1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2013年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
2
试验地点
1
主要终点
Time to Achieve Glycemic Target (HbA1c <7.5%).

研究概览

简要总结

This study is a pilot randomized controlled trial of 30 elderly type 2 diabetes patients conducted at the MODEL Clinical Research (MODEL), Research Division of Bay West Endocrinology Associates in Baltimore, Maryland. The investigators hypothesized that compared to a regimen base solely on traditional drugs, a regimen including newer drugs will achieve glycemic target faster and induce less hypoglycemia, weight gain, and other side effects, over the short run.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetics diagnosed for at least 6 months
  • Patients ages ≥ 65 years and older
  • Active patients in the Bay West Endocrinology practice
  • Inadequately controlled on oral agents and/or basal insulin with HbA1c between 8.0% and 12%
  • Eligible for randomization to either treatment group
  • Patients willing to follow either treatment arm including regimen using one or more injectables
  • Patients to have an English Reading Level of Grade 6 or above
  • Patients residing at home

排除标准

  • Unwilling to use a regimen that may contain using one or more injections
  • Using short acting insulin prior to the study
  • Using GLP-1 in past 10 weeks
  • History of hypoglycemia unawareness or episodes needing emergency intervention
  • End-stage renal disease
  • Blindness
  • Terminal illness

研究组 & 干预措施

Standard Treatment

Active Comparator

A regimen with traditional drugs only

干预措施: Standard Treatment (Drug)

Incretin-based Treatment

Experimental

A regimen including incretin-based drugs

干预措施: Incretin-Based Treatment (Drug)

结局指标

主要结局

Time to Achieve Glycemic Target (HbA1c <7.5%).

时间窗: 6 months

Data not analyzed due to n=1 each arm.

次要结局

  • Overall Hypoglycemia Measured by Glucose Meter(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验